{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:19:37Z","timestamp":1783401577689,"version":"3.54.6"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10067-026-08199-4","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:57:03Z","timestamp":1780412223000},"page":"4399-4412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High frequency of interstitial lung disease in Indian patients with adult- onset idiopathic inflammatory myopathy: Insights from a prospective observational cohort"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5313-7316","authenticated-orcid":false,"given":"Harikrishnan","family":"Gangadharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4580-4617","authenticated-orcid":false,"given":"Anusree Prasad","family":"Seetha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0751-8537","authenticated-orcid":false,"given":"Sajitha","family":"Musthafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6670-0661","authenticated-orcid":false,"given":"Sandra Pulickal","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6550-4800","authenticated-orcid":false,"given":"Sandra","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7220-0895","authenticated-orcid":false,"given":"Sajitha","family":"Krishnadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"1","key":"8199_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","volume":"7","author":"IE Lundberg","year":"2021","unstructured":"Lundberg IE, Fujimoto M, Vencovsky J et al (2021) Idiopathic inflammatory myopathies. Nat Rev Dis Primers 7(1):86","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"8199_CR2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10067-009-1110-6","volume":"28","author":"IJ Chen","year":"2009","unstructured":"Chen IJ, Jan Wu YJ, Lin CW et al (2009) Interstitial lung disease in polymyositis and dermatomyositis. Clin Rheumatol 28(6):639\u2013646","journal-title":"Clin Rheumatol"},{"issue":"5","key":"8199_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00408-016-9896-x","volume":"194","author":"C Johnson","year":"2016","unstructured":"Johnson C, Pinal-Fernandez I, Parikh R et al (2016) Assessment of mortality in autoimmune myositis with and without associated interstitial lung disease. Lung 194(5):733\u2013737","journal-title":"Lung"},{"issue":"8","key":"8199_CR4","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.rmed.2007.02.017","volume":"101","author":"J Won Huh","year":"2007","unstructured":"Won Huh J, Soon Kim D, Keun Lee C et al (2007) Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis. Respir Med 101(8):1761\u20131769","journal-title":"Respir Med"},{"issue":"12","key":"8199_CR5","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.3390\/medicina58121757","volume":"58","author":"S Palmucci","year":"2022","unstructured":"Palmucci S, Di Mari A, Cancemi G et al (2022) Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis. Medicina (Kaunas) 58(12):1757","journal-title":"Medicina (Kaunas)"},{"issue":"9","key":"8199_CR6","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L et al (2022) Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 205(9):e18\u2013e47","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"8199_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2478\/jtim-2022-0029","volume":"11","author":"H Cao","year":"2022","unstructured":"Cao H, Huang J, Chang J et al (2022) Predictors of progression in idiopathic inflammatory myopathies with interstitial lung disease. J Transl Int Med 11(1):46\u201356","journal-title":"J Transl Int Med"},{"issue":"12","key":"8199_CR8","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M et al (2017) 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76(12):1955\u20131964","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"8199_CR9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292(7):344\u20137","journal-title":"N Engl J Med"},{"issue":"8","key":"8199_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292(8):403\u20137","journal-title":"N Engl J Med"},{"issue":"6 Pt 1","key":"8199_CR11","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/0190-9622(91)70153-S","volume":"24","author":"RL Euwer","year":"1991","unstructured":"Euwer RL, Sontheimer RD (1991) Amyopathic Dermatomyositis (Dermatomyositis sin\u00e9 myositis). Presentation of six new cases and review of the literature. J Am Acad Dermatol 24(6 Pt 1):959\u2013966","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"8199_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20035","volume":"62","author":"LG Rider","year":"2010","unstructured":"Rider LG, Koziol D, Giannini EH et al (2010) Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken) 62(4):465\u2013472","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"8199_CR13","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum 65(11):2737\u20132747","journal-title":"Arthritis Rheum"},{"issue":"9","key":"8199_CR14","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D et al (2019) 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 71(9):1400\u20131412","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"8199_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R et al (2017) International Sj\u00f6gren\u2019s Syndrome Criteria Working Group. 2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sj\u00f6gren\u2019s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol 69(1):35\u201345","journal-title":"Arthritis Rheumatol"},{"key":"8199_CR16","first-page":"328","volume":"16","author":"D Alarcon-Segovia","year":"1989","unstructured":"Alarcon-Segovia D, Cardiel MH (1989) Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 16:328\u2013334","journal-title":"J Rheumatol"},{"issue":"9","key":"8199_CR17","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8199_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","volume":"28","author":"Y Allenbach","year":"2018","unstructured":"Allenbach Y, Mammen AL, Benveniste O, Stenzel W (2018) Immune-Mediated Necrotizing Myopathies Working Group. 224th ENMC International Workshop:: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016. Neuromuscul Disord 28(1):87\u201399","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"8199_CR19","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1378\/chest.10-0180","volume":"138","author":"GR Connors","year":"2010","unstructured":"Connors GR, Christopher-Stine L, Oddis CV, Danoff SK (2010) Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest 138(6):1464\u20131474","journal-title":"Chest"},{"issue":"5","key":"8199_CR20","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1136\/annrheumdis-2017-211400","volume":"76","author":"R Aggarwal","year":"2017","unstructured":"Aggarwal R, Rider LG, Ruperto N, International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation (2017) 2016 American College of Rheumatology\/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: an International Myositis Assessment and Clinical Studies Group\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis 76(5):792\u2013801","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"8199_CR21","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1378\/chest.93.3.580","volume":"93","author":"DA Mahler","year":"1988","unstructured":"Mahler DA, Wells CK (1988) Evaluation of clinical methods for rating dyspnea. Chest 93(3):580\u2013586","journal-title":"Chest"},{"issue":"6","key":"8199_CR22","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM et al (2013) An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188(6):733\u2013748","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"8199_CR23","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1183\/13993003.00150-2015","volume":"46","author":"A Fischer","year":"2015","unstructured":"Fischer A, Antoniou KM, Brown KK et al (2015) An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 46(4):976\u2013987","journal-title":"Eur Respir J"},{"issue":"8","key":"8199_CR24","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","volume":"200","author":"BL Graham","year":"2019","unstructured":"Graham BL, Steenbruggen I, Miller MR et al (2019) Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med 200(8):e70\u2013e88","journal-title":"Am J Respir Crit Care Med"},{"key":"8199_CR25","unstructured":"Allenbach Y, Uzunhan Y, Toquet S, et al (2020); French Myositis Network. Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases 95(1): 70-78"},{"key":"8199_CR26","unstructured":"The Jamovi Project [Internet]. jamovi; 2024 [cited 2025 Jun 9]. Available from:\u00a0https:\/\/www.jamovi.org"},{"issue":"4","key":"8199_CR27","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s40064-015-1013-8","volume":"28","author":"S Ikeda","year":"2015","unstructured":"Ikeda S, Arita M, Misaki K et al (2015) Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: A retrospective cohort study. Springerplus 28(4):240","journal-title":"Springerplus"},{"issue":"8","key":"8199_CR28","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2019.34.e55","volume":"34","author":"SK Cho","year":"2019","unstructured":"Cho SK, Kim H, Myung J et al (2019) Incidence and prevalence of idiopathic inflammatory myopathies in Korea: a nationwide population-based study. J Korean Med Sci 34(8):e55","journal-title":"J Korean Med Sci"},{"issue":"1","key":"8199_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.semarthrit.2020.11.009","volume":"51","author":"KY Sun","year":"2021","unstructured":"Sun KY, Fan Y, Wang YX, Zhong YJ, Wang GF (2021) Prevalence of interstitial lung disease in polymyositis and dermatomyositis: a meta-analysis from 2000 to 2020. Semin Arthritis Rheum 51(1):175\u2013191","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"8199_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103335","volume":"22","author":"H Wang","year":"2023","unstructured":"Wang H, Lv J, He J et al (2023) The prevalence and effects of treatments of rapidly progressive interstitial lung disease of dermatomyositis\/polymyositis adults: a systematic review and meta-analysis. Autoimmun Rev 22(8):103335","journal-title":"Autoimmun Rev"},{"issue":"9","key":"8199_CR31","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1093\/rheumatology\/keab001","volume":"60","author":"P Mehta","year":"2021","unstructured":"Mehta P, Agarwal V, Gupta L (2021) High early mortality in idiopathic inflammatory myopathies: results from the inception cohort at a tertiary care centre in northern India. Rheumatology (Oxford) 60(9):4281\u20134290","journal-title":"Rheumatology (Oxford)"},{"key":"8199_CR32","first-page":"1255","volume":"50","author":"R Porkodi","year":"2002","unstructured":"Porkodi R, Shanmuganandan K, Parthiban M, Madhavan R, Rajendran P (2002) Clinical spectrum of inflammatory myositis in South India \u2013 a ten year study. J Assoc Physicians India 50:1255\u20131258","journal-title":"J Assoc Physicians India"},{"issue":"4","key":"8199_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.31138\/mjr.280823.lto","volume":"34","author":"R Janardana","year":"2023","unstructured":"Janardana R, Kn S, Bhat V et al (2023) Long Term Outcomes in Idiopathic Inflammatory Myositis: An Observational Epidemiologic Study over 15 Years. Mediterr J Rheumatol 34(4):513\u2013524","journal-title":"Mediterr J Rheumatol"},{"key":"8199_CR34","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1002\/art.30513","volume":"63","author":"I Marie","year":"2011","unstructured":"Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF (2011) Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum 63:3439\u20133447","journal-title":"Arthritis Rheum"},{"key":"8199_CR35","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3760\/cma.j.issn.0366-6999.2010.05.002","volume":"123","author":"SY Ji","year":"2010","unstructured":"Ji SY, Zeng FQ, Guo Q et al (2010) Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study. Chin Med J (Engl) 123:517\u201322.36","journal-title":"Chin Med J (Engl)"},{"key":"8199_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155381","volume":"11","author":"L Zhang","year":"2016","unstructured":"Zhang L, Wu G, Gao D et al (2016) Factors associated with interstitial lung disease in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis. PLoS ONE 11:e0155381","journal-title":"PLoS ONE"},{"key":"8199_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.106134","volume":"172","author":"X Xing","year":"2020","unstructured":"Xing X, Li A, Li C (2020) Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis. Respir Med 172:106134","journal-title":"Respir Med"},{"issue":"7","key":"8199_CR38","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.autrev.2009.02.010","volume":"8","author":"J Schulte-Pelkum","year":"2009","unstructured":"Schulte-Pelkum J, Fritzler M, Mahler M (2009) Latest update on the Ro\/SS-A autoantibody system. Autoimmun Rev 8(7):632\u2013637","journal-title":"Autoimmun Rev"},{"issue":"11","key":"8199_CR39","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.1093\/rheumatology\/keac090","volume":"61","author":"X Gui","year":"2022","unstructured":"Gui X, Shenyun S, Ding H et al (2022) Anti-Ro52 antibodies are associated with the prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease. Rheumatology (Oxford) 61(11):4570\u20134578","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"8199_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003121","volume":"9","author":"E Zanatta","year":"2023","unstructured":"Zanatta E, Cocconcelli E, Castelli G et al (2023) Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort. RMD Open 9(3):e003121","journal-title":"RMD Open"},{"issue":"4","key":"8199_CR41","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02571-2021","volume":"60","author":"N Hambly","year":"2022","unstructured":"Hambly N, Farooqi MM, Dvorkin-Gheva A et al (2022) Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry. Eur Respir J 60(4):2102571","journal-title":"Eur Respir J"},{"key":"8199_CR42","first-page":"1096203","volume":"9","author":"TV Tzilas","year":"2023","unstructured":"Tzilas TV, Papaioannou O et al (2023) Clinical features and outcomes of patients with myositis associated-interstitial lung disease. Front Med (Lausanne) 9:1096203","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"8199_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098824","volume":"9","author":"T Fujisawa","year":"2014","unstructured":"Fujisawa T, Hozumi H, Kono M et al (2014) Prognostic factors for myositis-associated interstitial lung disease. PLoS ONE 9(6):e98824","journal-title":"PLoS ONE"},{"issue":"11","key":"8199_CR44","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.rmed.2015.09.015","volume":"109","author":"NW Todd","year":"2015","unstructured":"Todd NW, Marciniak ET, Sachdeva A et al (2015) Organizing pneumonia\/non-specific interstitial pneumonia overlap is associated with unfavorable lung disease progression. Respir Med 109(11):1460\u20131468","journal-title":"Respir Med"},{"issue":"26","key":"8199_CR45","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000175","volume":"93","author":"S Yoshizawa","year":"2014","unstructured":"Yoshizawa S, Suenaga Y, Ogushi F et al (2014) Predictors of mortality in patients with interstitial lung disease treated with corticosteroids: results from a cohort study. Medicine (Baltimore) 93(26):e175","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"8199_CR46","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00296-021-04897-1","volume":"42","author":"SK Dunga","year":"2022","unstructured":"Dunga SK, Kavadichanda C, Gupta L, Naveen R, Agarwal V, Negi VS (2022) Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study. Rheumatol Int 42(7):1155\u20131165","journal-title":"Rheumatol Int"},{"issue":"4","key":"8199_CR47","doi-asserted-by":"publisher","first-page":"413","DOI":"10.31138\/mjr.33.4.413","volume":"33","author":"P Devarasetti","year":"2022","unstructured":"Devarasetti P, Mohammad I, Desai A, Rajasekhar L (2022) Fever, cutaneous ulcers, and arthritis define the MDA5 phenotype in Indian patients with idiopathic inflammatory myositis. Mediterr J Rheumatol 33(4):413\u2013420","journal-title":"Mediterr J Rheumatol"},{"key":"8199_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2026.152967","volume":"78","author":"KE Moore","year":"2026","unstructured":"Moore KE, Khoo T, Limaye V, Ali SB (2026) Immune dysregulation and infection susceptibility in anti-MDA5 dermatomyositis. Semin Arthritis Rheum 78:152967","journal-title":"Semin Arthritis Rheum"},{"key":"8199_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.740154","volume":"8","author":"L Huang","year":"2021","unstructured":"Huang L, Zhu W, Ye Y et al (2021) Association of cytomegalovirus infection with anti-MDA5 antibody-positive dermatomyositis: a prospective cohort study. Front Med (Lausanne) 8:740154","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"8199_CR50","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s12088-024-01333-3","volume":"65","author":"M Zhang","year":"2025","unstructured":"Zhang M, Yan B (2025) The characteristics and risk factors of cytomegalovirus infection in dermatomyositis. Indian J Microbiol 65(2):1173\u20131180","journal-title":"Indian J Microbiol"},{"key":"8199_CR51","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","volume":"380","author":"O Distler","year":"2019","unstructured":"Distler O, Highland KB, Gahlemann M et al (2019) Nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med 380:2518\u20132528","journal-title":"N Engl J Med"},{"issue":"18","key":"8199_CR52","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty KR, Wells AU, Cottin V et al (2019) Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 381(18):1718\u20131727","journal-title":"N Engl J Med"},{"key":"8199_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/srep33226","volume":"6","author":"T Li","year":"2016","unstructured":"Li T, Guo L, Chen Z et al (2016) Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis. Sci Rep 6:33226","journal-title":"Sci Rep"},{"key":"8199_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.626953","volume":"8","author":"J Liang","year":"2021","unstructured":"Liang J, Cao H, Yang Y et al (2021) Efficacy and tolerability of nintedanib in idiopathic-inflammatory-myopathy-related interstitial lung disease: a pilot study. Front Med 8:626953","journal-title":"Front Med"},{"key":"8199_CR55","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X211060907","volume":"13","author":"EM Wilfong","year":"2021","unstructured":"Wilfong EM, Aggarwal R (2021) Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease. Ther Adv Musculoskelet Dis 13:1759720X211060907","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"9","key":"8199_CR56","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1093\/rheumatology\/keae167","volume":"63","author":"A Loganathan","year":"2024","unstructured":"Loganathan A, Gupta L, Rudge A et al (2024) Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohort. Rheumatology (Oxford) 63(9):2363\u20132371","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"8199_CR57","first-page":"36","volume":"69","author":"L Rajasekhar","year":"2021","unstructured":"Rajasekhar L, Shobha V, Narasimhan A, Bhat V, Amin SN, Misra R (2021) Prevalence and clinical correlates of myositis specific autoantibodies in idiopathic immune-mediated inflammatory myositis - results from a multicentric cohort (MyoIN) from India. J Assoc Physicians India 69(1):36\u201340","journal-title":"J Assoc Physicians India"},{"issue":"7","key":"8199_CR58","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00296-016-3494-3","volume":"36","author":"P Srivastava","year":"2016","unstructured":"Srivastava P, Dwivedi S, Misra R (2016) Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis. Rheumatol Int 36(7):935\u2013943","journal-title":"Rheumatol Int"},{"issue":"7","key":"8199_CR59","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1093\/rheumatology\/keaf101","volume":"64","author":"X Wei","year":"2025","unstructured":"Wei X, Yun J, He J, Sturgess A (2025) Cut-off matters in the interpretation of myositis antibodies by line immunoassay. Rheumatology (Oxford) 64(7):4364\u20134370","journal-title":"Rheumatology (Oxford)"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08199-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08199-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08199-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:03:29Z","timestamp":1783400609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08199-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["8199"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08199-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all the participants. The study was approved by the institutional ethics committee (IRB No: 290\/2023). The study adhered to the rules laid by the Declaration of Helsinki, 2013.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}